These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7310494)

  • 1. Oxygenated fluorocarbon perfusion as treatment of acute spinal cord compression injury in dogs.
    Hansebout RR; van der Jagt RH; Sohal SS; Little JR
    J Neurosurg; 1981 Nov; 55(5):725-32. PubMed ID: 7310494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of fluorocarbon reperfusion on postoperative cardiac dysfunction of transplanted heart.
    Ueda K; Genda T; Hirata I; Shimada M; Shibata T; Ueda T; Omoto R
    J Heart Lung Transplant; 1992; 11(4 Pt 1):646-55. PubMed ID: 1498127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%).
    Kolodgie FD; Virmani R; Farb A
    J Am Coll Cardiol; 1991 Jul; 18(1):215-23. PubMed ID: 2050924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygenated fluorocarbon nutrient solution in the treatment of experimental spinal cord injury.
    Osterholm JL; Alderman JB; Triolo AJ; D'Amore BR; Williams HD
    Neurosurgery; 1984 Sep; 15(3):373-80. PubMed ID: 6237276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal perfusion of an oxygenated perfluorocarbon prevents paraplegia after aortic occlusion.
    Maughan RE; Mohan C; Nathan IM; Ascer E; Damiani P; Jacobowitz IJ; Cunningham JN; Marini CP
    Ann Thorac Surg; 1992 Nov; 54(5):818-24; discussion 824-5. PubMed ID: 1417270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive effect of Fluosol-DA for paraplegia encountered after surgical treatment of the thoracic aorta. Preliminary results in a dog model.
    DelRossi AJ; Cernaianu AC; Cilley JH; Spence RK; Camishion RC; Yu Y; Costabile JP; Vertrees RA
    J Thorac Cardiovasc Surg; 1990 Apr; 99(4):665-9. PubMed ID: 2319788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Fluosol-DA on infarct morphology and vulnerability to ventricular arrhythmia.
    Kolodgie FD; Dawson AK; Roden DM; Forman MB; Virmani R
    Am Heart J; 1986 Dec; 112(6):1192-201. PubMed ID: 3788766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against ischemia during prolonged balloon inflation by distal coronary perfusion with use of an autoperfusion catheter or Fluosol.
    Robalino BD; Marwick T; Lafont A; Vaska K; Whitlow PL
    J Am Coll Cardiol; 1992 Nov; 20(6):1378-84. PubMed ID: 1430688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective effect of fluosol-DA in acute cerebral ischemia (author's transl)].
    Ishikawa R; Peerless SJ; Hunter IG
    No Shinkei Geka; 1981 Dec; 9(13):1503-8. PubMed ID: 6808409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present status of clinical studies of Fluosol-DA (20%) in Japan.
    Mitsuno T; Ohyanagi H
    Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.
    Cleman M; Jaffee CC; Wohlgelernter D
    Circulation; 1986 Sep; 74(3):555-62. PubMed ID: 2943533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental studies on fluosol DA administration in acute pancreatitis.
    Ohyanagi H; Ohashi O; Nakayama S; Yamamoto M; Okumura S; Saitoh Y
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):585-94. PubMed ID: 3179491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of blood and Fluosol-DA for cardiopulmonary bypass.
    Rousou JA; Engelman RM; Anisimowicz L; Dobbs WA
    J Cardiovasc Surg (Torino); 1985; 26(5):447-53. PubMed ID: 4030876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hemodilution with dextran, stroma-free hemoglobin solution and fluosol-DA on experimental myocardial ischemia in the dog.
    Biro GP
    Bibl Haematol; 1981; (47):54-69. PubMed ID: 6175307
    [No Abstract]   [Full Text] [Related]  

  • 15. [An experimental study on the effect of fluorocarbon perfusion for the preservation of an amputated limb].
    Takahashi F
    Nihon Seikeigeka Gakkai Zasshi; 1987 Oct; 61(10):1123-34. PubMed ID: 3437177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of Fluosol-DA in acute cerebral ischemia.
    Peerless SJ; Ishikawa R; Hunter IG; Peerless MJ
    Stroke; 1981; 12(5):558-63. PubMed ID: 6795765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.
    Acar C; Partington MT; Buckberg GD
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of the extent of ischemic skeletal muscle necrosis by perfusion with oxygenated perfluorocarbon.
    Mohan C; Gennaro M; Marini C; Ascer E
    Am J Surg; 1992 Sep; 164(3):194-8. PubMed ID: 1329572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluocarbon exchange transfusion on myocardial infarction size in dogs.
    Nunn GR; Dance G; Peters J; Cohn LH
    Am J Cardiol; 1983 Jul; 52(1):203-5. PubMed ID: 6858913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the perfluorocarbon Fluosol-DA in coronary angioplasty.
    Kerins DM
    Am J Med Sci; 1994 Mar; 307(3):218-21. PubMed ID: 8160713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.